Funding New Zealand's public healthcare system: time for an honest appraisal and public debate.
暂无分享,去创建一个
Ian Powell | Bill Rosenberg | M. Nicholls | C. Frampton | Bill Rosenberg | M Gary Nicholls | Lyndon Keene | Philip Bagshaw | Christopher M Frampton | P. Bagshaw | I. Powell | L. Keene
[1] National Accounts at a glance , 2008 .
[2] Gareth Iacobucci. NHS needs emergency injection of £1bn, says King’s Fund , 2015, British medical journal.
[3] M. Cooper. Core services and the New Zealand health reforms. , 1995, British medical bulletin.
[4] G. Juckett,et al. Impetigo: diagnosis and treatment. , 2014, American family physician.
[5] R. Devol,et al. An Unhealthy America:The Economic Burden of Chronic Disease , 2007 .
[6] P. Scuffham,et al. Incidence of acute rheumatic fever in New Zealand children and youth , 2012, Journal of paediatrics and child health.
[7] J. Boston. Child Poverty in New Zealand: Why it matters and how it can be reduced , 2014 .
[8] E. Kaplan. Recent evaluation of antimicrobial resistance in beta-hemolytic streptococci. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] P. Crampton,et al. Sore throat management in New Zealand general practice. , 2005, The New Zealand medical journal.
[10] J. Hennessy,et al. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. , 1985, The Journal of pediatrics.
[11] P. Scuffham,et al. Burden and Cost of Rheumatic Fever and Rheumatic Heart Disease in New Zealand: Focus on School Age Children A Report to the Ministry of Health. , 2010 .
[12] D. Lennon,et al. Once-daily amoxicillin versus twice-daily penicillin V in group A β-haemolytic streptococcal pharyngitis , 2008, Archives of Disease in Childhood.
[13] M. Baker,et al. Increasing hospitalizations for serious skin infections in New Zealand children, 1990–2007 , 2010, Epidemiology and Infection.
[14] S. Popova,et al. Economic Cost of Chronic Disease in Canada 1995-2003 , 2007 .
[15] B. Easton. The New Zealand health reforms of the 1990s in context. , 2002, Applied health economics and health policy.
[16] A. Reeves,et al. Does investment in the health sector promote or inhibit economic growth? , 2013, Journal of Epidemiology & Community Health.
[17] D. Black,et al. Working for a healthier Tomorrow: Dame Carol Black's review , 2008 .
[18] D Fraser,et al. Unshackling the hospitals. , 1988, The New Zealand medical journal.
[19] K. Grimwood,et al. Monitoring the health of New Zealand children and young people: Indicator handbook , 2007 .
[20] M. Tobias,et al. Population Ageing and Government Health Expenditures in New Zealand, 1951-2051 , 2004 .
[21] P. Cochat,et al. Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[22] S. Monecke,et al. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] M. Mckee,et al. How can health systems respond to population ageing , 2009 .
[24] M. Cooper. Jumping on the spot--health reform New Zealand style. , 1994, Health Economics.
[25] N. Burrows,et al. Fusidic acid resistance in Staphylococcus aureus , 2017 .
[26] H. Goossens,et al. Antibiotic resistance—the need for global solutions , 2013, BDJ.
[27] D. Lennon,et al. Registered nurse assessment and treatment of skin sepsis in New Zealand schools: the development of protocols. , 2013, The New Zealand medical journal.
[28] A. Verhagen,et al. Interventions for impetigo. , 2004, The Cochrane database of systematic reviews.
[29] Patrick Richard,et al. The Economic Burden of Health Inequalities in the United States , 2009 .
[30] B. Howden,et al. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] K. Walshe,et al. Comprehensive spending review and the NHS , 2015, British medical journal.
[32] S. Schrag,et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] Bryan Perry,et al. Household incomes in New Zealand: trends in indicators of inequality and hardship 1982 to 2004 , 2016 .
[34] M. Nicholls,et al. The importance of measuring unmet healthcare needs. , 2014, The New Zealand medical journal.
[35] Alesha J. Smith,et al. Rising antimicrobial resistance: a strong reason to reduce excessive antimicrobial consumption in New Zealand. , 2014, The New Zealand medical journal.